Drugs like Ozempic and Wegovy, called GLP-1 agonists, carry more benefits than risks when taken for their approved uses, according to a comprehensive analysis of their effects on 175 conditions.

About 215,000 used GLP-1 drugs, while the rest were taking various other diabetes medications. Though semaglutides like Ozempic and Wegovy dominate the market in the U.S., Al-Aly and his team ...

The GLP-1 medications approved by Health Canada include Ozempic and Wegovy. These drugs have become popular in the past few years thanks to their weight-loss benefits by extending how long people ...

Weight-loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists include Ozempic, Mounjaro, Wegovy and Zepbound—and they can be prescribed for obesity or type 2 diabetes.

FILE – The injectable drug Ozempic is shown, July 1, 2023, in Houston. (AP Photo/David J. Phillip, File) Under the law, more drugs will be added to the negotiation process in coming years.

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been ... generate about $6 billion for taxpayers and $1.5 billion for Medicare enrollees.

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

For more audio journalism and storytelling, download New York Times Audio, a new iOS app available for news subscribers. Hosted by Sabrina Tavernise Featuring Coral Davenport Produced by Rob ...

GLP-1's release is stimulated by certain foods and gut microbes, and its mechanism of action is mimicked by drugs like semaglutide (the ingredient behind Ozempic). People with type 2 diabetes ...